Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Amortizatization of Intangibles (2018 - 2025)

Historic Amortizatization of Intangibles for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2025 value amounting to $842000.0.

  • Organogenesis Holdings' Amortizatization of Intangibles rose 95.92% to $842000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 565.94%. This contributed to the annual value of $8.3 million for FY2024, which is 327.85% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Amortizatization of Intangibles stood at $842000.0, which was up 95.92% from $841000.0 recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Amortizatization of Intangibles ranged from a high of $2.2 million in Q1 2024 and a low of $834000.0 during Q2 2024
  • Its 5-year average for Amortizatization of Intangibles is $1.5 million, with a median of $1.2 million in 2021.
  • In the last 5 years, Organogenesis Holdings' Amortizatization of Intangibles skyrocketed by 5232.84% in 2021 and then crashed by 3214.0% in 2024.
  • Over the past 5 years, Organogenesis Holdings' Amortizatization of Intangibles (Quarter) stood at $1.8 million in 2021, then decreased by 0.49% to $1.8 million in 2022, then rose by 16.43% to $2.1 million in 2023, then decreased by 6.98% to $2.0 million in 2024, then plummeted by 57.28% to $842000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $842000.0 for Q3 2025, versus $841000.0 for Q2 2025 and $2.0 million for Q1 2025.